Instrument Inactif

Autres langues Guided Therapeutics Inc OTC Bulletin Board

Actions

US40171F1057

Equipement et technologie médicale avancés

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

16/06	Guided Therapeutics dépose le rapport clinique de sa demande d'homologation auprès de la FDA	CI
15/05	Guided Therapeutics, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

16/06	Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
16/06	Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
15/05	Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
31/03	Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
31/03	Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
31/03	Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
17/12	Guided Therapeutics, Inc. Announces Preliminary Findings from Its FDA Pivotal Clinical Trial
17/12	Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
11/12	Guided Therapeutics, Inc. Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
11/12	Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
19/11	Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
19/11	Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
13/11	Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
19/08/25	Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings
19/08/25	Guided Therapeutics, Inc. Receives $70,000 from New Chinese Distribution Partner That Provides Products for 2 Million Annual Cervical Cancer Screenings
14/08/25	Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
13/08/25	Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial
13/08/25	Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial
02/07/25	Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd
02/07/25	Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
10/06/25	Guided Therapeutics, Inc. Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor
10/06/25	Guided Therapeutics Receives $700,000 Purchase Order And Initial Payment From New Chinese Distributor
10/06/25	Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor
27/05/25	Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China
15/05/25	Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025